期刊文献+

2株海洋来源产浅蓝霉素A的异壁放线菌的分离和鉴定 被引量:1

Isolation and Identification of Two Marine-Originated Actinoalloteichus sp. Producing Caerulomycin A
下载PDF
导出
摘要 利用抗菌及卤虫致死活性模型,从中国南海海底沉积物来源的微生物中筛选到2株放线菌SCSIO WJ01和SCSIO ZJ63,其发酵产物具有较强活性,经16S rRNA基因序列分析这2株放线菌均为异壁放线菌Actinoalloteichus sp.。HPLC-DAD分析显示2株放线菌能产生同一个主要的次级代谢产物,通过正相硅胶柱色谱、反相中压柱色谱、半制备高效液相色谱等手段,从SCSIO WJ01的发酵产物中分离获得了该化合物,运用ESI-MS、1H及13C NMR波谱分析鉴定为浅蓝霉素A(Caerulomycin A)。此外,还从SCSIO WJ01的发酵产物中分离鉴定了浅蓝霉素D。 Two marine-originated actinobacteria strains SCSIO WJ01 and SCSIO ZJ63 isolated and screened from sediments collected in the bottom of South China Sea,using antibiotic and lethal activities model against brine shrimp( Artemia salina),their fermentation broths possessed fairly strong activity. These two strains were identified as Actinoalloteichus sp. through 16 S rRNA gene sequence analysis. HPLC-DAD analysis disclosed that strains SCSIO WJ01 and SCSIO ZJ63 could produce the same major secondary metabolite. These fermentation products were isolated from the fermentation extract of strain SCSIO WJ01 by means of ortho-phase silica gel column chromatography and counterphase mid-pressure column chromatography,and semi-preparative HPLC etc and identified to be caerulomycin A using ESI-MS,1H and13 C NMR spectroscopic analyses. In addition,caerulomycin D was also isolated and identified from fermentation product of strain SCSIO WJ01.
出处 《微生物学杂志》 CAS CSCD 2015年第1期24-29,共6页 Journal of Microbiology
基金 国家自然科学青年基金项目(41106138 41206135) 中国科学院知识创新工程青年人才领域前沿项目(SQ201119)
关键词 海洋放线菌 异壁放线菌属 浅蓝霉素 联吡啶 marine Actinomycetes Actinoalloteichus caerulomycin dipyridines
  • 相关文献

参考文献21

  • 1Koehn F. E, , Carter G. T, The evolving role of natural prod- ucts in drug discovery [ J ]. Nature Reviews Drug Discovery, 2005,4(3) :206-220.
  • 2Newman D, J. , Cragg G. M, Natural products as sources of new drugs over the 30 years from 1981 to 2010[J]. Journal of natural products,2012,75 ( 3 ) : 311-335.
  • 3Yuliana N. D. , Khatib A. , Choi Y. H. , et al. Metabolomics for bioactivity assessment of natural products[J]. Phytotherapy research, 2011,25 ( 2 ) : 157 -169.
  • 4Dharmaraj S. Marine Streptomyces as a novel source of bioac- tive substances[ J]. World Journal of Microbiology and Biotech- nology ,2010,26 ( 12 ) :2123-2139.
  • 5Fenical W. , Jensen P.R. Developing a new resource for drug discovery: marine actinomycete bacteria [ J ]. Nature chemical biology,2006,2(12) :666-673.
  • 6Chen Q. , Ji C. T. , Song Y. X. , et al. Discovery of McbB, an enzyme catalyzing the β-earboline skeleton construction in the marinacarboline biosynthetic pathway [ J ]. Angewandte Chemie, 2013,125(38) :10164-10168.
  • 7Huang H. B. , Yao Y. L. , He Z. X. , et al. Antimalarial β- carboline and indolactam alkaloids from Marinactinospora ther- motolerans, a deep sea isolate[ J]. Journal of natural products, 2011,74(10) :2122-2127.
  • 8Zhou X, Huang H. B. ,Chen Y. C. , et al. Marthiapeptide A, an anti-infective and cytotoxic polythiazole cyclopeptide from a 60 L scale fermentation of the deep sea-derived Marinactinospo-ra thermotolerans SCSIO 00652 [ J ]. Journal of natural prod- ucts,2012,75 (12) :2251-2255.
  • 9Tian X. P. , Tang S. K. , Dong J. D. , et al. Marinactirtospora thermotolerans gen. nov. , sp. nov. , a marine actinomycete i- solated from a sediment in the northern South China Sea [ J ]. International journal of systematic and evolutionary microbiolo- gy ,2009,59 ( 5 ) :948-952.
  • 10Huang H. B, Yang T. T. , Ren X. M. , et al. Cytotoxic an- gucycline class glycosides from the deep sea actinomycete Strep- tomyces lusitanus SCSIO LR32 [ J]. Journal of natural products, 2012,75(2) :202-208.

同被引文献4

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部